MJNA Stock Looking To Be A Nickel Bag With Less Shake

The month of August, for anyone who has ever actually grown outdoors themselves, has proven to be a great month for Marijuana plant growth just prior to the change of seasons. It is also proving to be a great month for Medical Marijuana Inc. (MJNA) whose stock price has risen 65.45% ...

Continue Reading →
0

Dude, Where’s My Penny Stock Phototron (PHOT)?

The penny stock of Phototron Holdings, Inc. (PHOT), a leading technology supplier to the hydroponic growing industry, is about to go Snoop Dogg. PHOT stock price closed down -13.64% at 0.05 on volume of just 367,785 shares traded on Wednesday. Those numbers are meaningless because the #1 choice of organic hydroponic home growers is on the pump and you can expect it to ...

Continue Reading →
0

Chew On This: Medical Marijuana MJNA 50% Stake in CanChew

After doubling in price to start the month of May, the stock price of Medical Marijuana, Inc. (OTC PINK: MJNA) has dropped over -50% to 0.042. That’s about to be corrected now that MJNA, a leading cannabis and hemp industry innovator, acquired a 50% interest in CanChew, ...

Continue Reading →
0

MJNA: Medical Marijuana Price has Doubled since April 30

One of the best penny stock picks we had to start the year was Cannabis Science Inc. (OTC: CBIS). We issued an alert on the penny stock when CBIS was under ...

Continue Reading →
0

Will Cannabis Science (CBIS) Be a Smoking Hot Penny Stock?

One of the cheap OTCBB penny stocks, Cannabis Science (OTC: CBIS) is less than 24 hours from their non-sanctioned annual holiday: April 20, 420. CBIS was a volume leader as the year began and has been a most traded leader for the last few months since rising from a literal penny to almost a quarter, $0.2455. The penny stock of the medical marijuana ...

Continue Reading →
0

Cannabis Science (CBIS) Reports 2012 Outlook For Company

Medical Marijuana and helping to legalize Marijuana for Medicinal purposes is the focus of Penny Stock Cannabis Science, Inc. (OTC: CBIS.OB).  The Company announced today a fourth (4th) skin cancer patient who is showing improvements from self-administered CBIS product use.

CBIS traded as high as $0.046 in today’s trading session.
CBIS closing ...

Continue Reading →
0

Cannabis Science Presents Visuals Of Cancer Tumors Dying

Cannabis Science, Inc. (OTCBB: CBIS.OB), a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, shared new photographs from this cancer patient with severe squamous cell carcinoma.

These pictures clearly show that this patient, with previously treatment-resistant tumors, continues to make obvious improvement. The tumors appear to be dying and then ...

Continue Reading →
0